Susan Hasty, Publisher
Table of Contents . . . October 8th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV Transmission - Langerhans Cells Express Functional CXCR4
HIV Vaccines - Shigella-Based Vector Causes Specific Immune Response
Epidemiology - Major AIDS Studies To Increase Minority Enrollment, Answer New Questions
HIV Pathology - Interferon-Producing Cell Levels Linked To Progression Risk
HIV Vaccines - Recombinant Influenza Vectors Produce Antiviral Response
Pathogenesis - AIDS Virus's Ability To Mimic Other Infections Weakens the Body's Defenses
AIDS Therapies - Companies Expand Access To Nevirapine Donation Program
AIDS Therapies - Epimmune Provides HIV Vaccine Program Update
AIDS Therapies - Immune Regulating Hormone Impacts Inflammation and Immune Suppression
AIDS Therapies - Many HIV Patients Fail To Follow Antiretroviral Medication Regimen
AIDS Therapies - New Technology May Advance AIDS Vaccine Development
AIDS Therapies - Promising Preclinical Results With Immunotherapeutic Agent
AIDS Therapies - Vaccine Employing Novel Vector Protects Monkeys From Monkey-Human Hybrid Virus
Cell Biology - Blinding Cells To Chemokines Might Prevent Autoimmune Diseases
Clinical Trials - AIDS Vaccine Testing To Accelerate In Uganda
Clinical Trials - Vaccinated Monkeys Pass 600-Day Mark With No Illness
Disease Association - Hepatitis C, HIV Make Interesting Combination
Disease Associations - HIV Patients Coinfected With HGV Show Increased Survival
HIV Vaccines - Modified Vaccinia Virus Ankara Repeat Dosing May Limit Effectiveness
Knowledge, Attitudes, and Behavior - AIDS Community Exhibits Hope, Determination, Compassion
Pulmonary TB Risk Factor - High Iron Intake Linked To Development
Vascular Disease - Antibody Found To Destroy Platelets
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.